What Happened to Agent Orange?

Agent Orange is the code name for one of the 'Rainbow Herbicides' used by the U.S. military during the Vietnam War as part of Operation Ranch Hand, a program of herbicidal warfare conducted from 1962 to 1971. The defoliant was a 50/50 mixture of two herbicides, 2,4-D and 2,4,5-T, but its devastating long-term effects stem from its contamination with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a highly toxic dioxin byproduct of the manufacturing process [1, 7, 33]. Approximately 20 million gallons of various herbicides, primarily Agent Orange, were sprayed over Vietnam, eastern Laos, and parts of Cambodia, affecting an estimated 12 percent of South Vietnam's total area [1, 2, 18].

The primary objective of spraying Agent Orange was tactical: to defoliate dense jungle foliage that provided cover for Viet Cong and North Vietnamese forces, and to destroy enemy food crops [1, 8, 12]. At the time, U.S. officials often dismissed concerns about its safety, with some even claiming it was harmless to humans [27, 35]. However, the dioxin in Agent Orange is a persistent organic pollutant that accumulates in fatty tissues and remains in the environment for decades, impacting the food chain and posing a continuous health hazard [7, 8, 35].

Key turning points in addressing the Agent Orange legacy include the growing reports of health issues among veterans in the years following the war, leading to the establishment of the Agent Orange Registry health examination program in 1978 by the Veterans Administration [4, 9]. A significant development was the 1989 Nehmer v. U.S. Department of Veterans Affairs lawsuit, which challenged the VA's limited compensation for Agent Orange-related conditions and led to the 1991 Agent Orange Act. This act established presumptive conditions for veterans, easing the burden of proof for service-connected disabilities [9, 11, 22, 29]. In 2004, a lawsuit by Vietnamese victims seeking compensation from chemical manufacturers was rejected by a U.S. court [8].

The consequences of Agent Orange exposure are profound and ongoing. Millions of U.S. veterans and Vietnamese citizens have suffered from a wide array of health problems, including various cancers (bladder, prostate, lung, non-Hodgkin's lymphoma, multiple myeloma, chronic B-cell leukemias), Type 2 diabetes, ischemic heart disease, Parkinson's disease, hypertension, hypothyroidism, and chloracne [2, 3, 7, 14, 16, 32]. The Vietnamese government estimates that up to four million people were exposed, with as many as three million suffering illnesses and half a million babies born with birth defects [1, 8, 35]. While the U.S. government has documented cases of birth defects in children of exposed U.S. veterans, particularly spina bifida, the scope of recognized conditions for children, especially those of male veterans, remains a contentious issue [14, 20, 21, 25].

As of September 2, 2026, the legacy of Agent Orange continues to be addressed through expanded veteran benefits and ongoing advocacy. The Honoring Our Promise to Address Comprehensive Toxics (PACT) Act of 2202 added new presumptive conditions, such as hypertension and monoclonal gammopathy of undetermined significance (MGUS), and expanded eligibility for veterans who served in locations like Thailand, Laos, and Cambodia [12, 14, 31, 36]. The VA continues to recognize a broad list of presumptive conditions, simplifying the claims process for eligible veterans [10, 19, 32]. However, legal challenges persist, with a federal lawsuit filed in April 2026 by a Vietnam veteran and his daughter, challenging the sex-based discrimination in VA benefits for birth defects, as current laws primarily cover children of female veterans [20, 21, 30]. Cleanup efforts for dioxin-contaminated hotspots in Vietnam, particularly former U.S. airbases, are also ongoing, though the environmental and health impacts are expected to last for many more years.